(RSP) SP500 Equal Weight - Overview
Etf: Stocks, Equities, S&P 500, Equal-Weight
Dividends
| Dividend Yield | 1.70% |
| Yield on Cost 5y | 2.54% |
| Yield CAGR 5y | 10.86% |
| Payout Consistency | 97.8% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 12.5% |
| Relative Tail Risk | -0.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.48 |
| Alpha | -0.14 |
| Character TTM | |
|---|---|
| Beta | 0.811 |
| Beta Downside | 0.849 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.81% |
| CAGR/Max DD | 0.65 |
Description: RSP SP500 Equal Weight January 27, 2026
The Invesco S&P 500® Equal Weight ETF (RSP) seeks to track an equal-weight version of the S&P 500, allocating at least 90 % of its assets to the 500 constituent stocks of that index. By giving each component roughly the same weight, the fund departs from the market-cap weighting of the standard S&P 500, aiming for a more balanced exposure across large-cap U.S. equities.
As of 31 Dec 2025, RSP reported approximately $13 billion in assets under management, an expense ratio of 0.20 % (net), and a 12-month total return of +9.4 % (versus +11.2 % for the cap-weighted S&P 500). The ETF’s sector composition is roughly flat, with the top five sectors-Information Technology, Health Care, Financials, Consumer Discretionary, and Industrials-each representing about 4-5 % of the portfolio, reflecting the equal-weight methodology. Recent macro drivers include the Federal Reserve’s policy-rate range of 5.25-5.50 % and a year-over-year U.S. GDP growth of 2.1 %, both of which tend to favor diversified large-cap exposure while limiting concentration risk.
Given the fund’s tilt toward a more uniform sector balance, investors should monitor how sector-specific earnings cycles (e.g., tech valuation corrections or health-care policy shifts) could affect relative performance; a sustained divergence in sector momentum would materially alter RSP’s risk-return profile.
For a deeper, data-rich analysis of RSP’s valuation metrics and scenario testing, you might explore the free tools on ValueRay.
What is the price of RSP shares?
Over the past week, the price has changed by +0.02%, over one month by +2.01%, over three months by +6.42% and over the past year by +11.39%.
Is RSP a buy, sell or hold?
What are the forecasts/targets for the RSP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 220.9 | 11.2% |
RSP Fundamental Data Overview January 31, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 82.72b USD (82.72b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 82.72b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 82.72b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.90% (E(82.72b)/V(82.72b) * Re(8.90%) + (debt-free company))
Discount Rate = 8.90% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)